AzTrials
AzTrials

L-PRFNCT06719648

Root Coverage for Gingival Recessions: a Randomized Clinical Trial Using Coronally Advanced Tunnel Technique and Novomatrix®

A study testing Acellular dermal matrix + L-Prf and Connective Tissue graft + L-Prf in people with L-PRF and Surgery, run by Universitat Internacional de Catalunya at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomized clinical trial comparing the modified tunnel technique with the use of acellular xenogeneic matrix and connective tissue with the use leucocyte platlet rich fibrin (L-PRF) Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
L-PRF, Surgery
What is being tested?
Acellular dermal matrix + L-Prf and Connective Tissue graft + L-Prf
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteSpain
Study dates
20 May 2020to 28 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age >18 years
  • Presence of 2 or more adjacent Cairo's type I or II gingival recessions
  • Non-smokers
  • Plaque index <20% and bleeding on probing (BOP) <20%
  • Periodontal health
  • Existing endodontic therapies must be carefully evaluated. In case of inadequate treatments, endodontic retreatment will be performed (i.e., a minimum of two months before performing the surgical therapy).
  • Use of optical magnification (2.5X) and microsurgical instruments for the surgical procedure is recommended.

Who cannot join

  • Individuals who do not meet the inclusion criteria
  • Systemic compromise involving healing response and tissue repair, or coagulation disorders
  • Uncontrolled systemic diseases
  • Use of anticoagulant therapy or bisphosphonates
  • Active periodontal disease
  • Inadequate psychological profile
  • Patients with intentions to change residence that would prevent follow-up
  • Multiple recessions in molars

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Isabel Arroyo

    Barcelona, Barcelona, 08037

Other trials in Spain

About this study

Official title: Multiple Gingival Recessions Root Coverage Using Coronally Advanced Tunnel Technique Combined with a Xenogenic Dermal Matrix (Novomatrix®): a Randomized Clinical Trial

A randomized clinical trial comparing the modified tunnel technique with the use of acellular xenogeneic matrix and connective tissue with the use leucocyte platlet rich fibrin (L-PRF)

Read the detailed description

Study design In the pre-surgical clinical evaluation periodontal measurements were registered at baseline and during the follow-up period: periodontal probing depth (PPD), clinical attachment level (CAL), width and length (mm) of the GR, type of GR, amount of attached gingiva (mm), depth of vestibule (mm), interdental papilla height (mm), non carious cervical lesions, visual LAC detection, gingival thickness (mm) and gingival phenotype (translucency of the periodontal probe). Intraoral photographs always showing a frontal view of the treated area were taken. Moreover, all patients received supragingival scaling and crown polishing. Patient were instructed to rinse with 0.12% Chlorhexidine, 2 times a day for 1 minute starting one week prior to the surgery. Local etiological factors in the area of treatment were controlled or modified, such as the removal and change of overflowing seals, the polishing of restorations, the adjustment of margins. In cases where the cement enamel junction is not clearly detected a reconstruction of this with resin was carried out. Finally, prior to surgery, anti-inflammatory treatment were prescribed to the patient from the day before surgery with Ibuprofen 400 mg, 1 every 8 hours for 7 days

Clinical Procedures:

Prior to surgical procedure, a sealed envelope was opened with the treatment modality (randomization table). Local infiltration anesthesia was performed on both sides (buccal and lingual/palatal) of the affected area. The surgical protocol was performed following the tunnel technique described by Allen (1994) and using microsurgical instruments for periodontal plastic surgery [KPA Allen, PPAELA, tunelisation knife black line, (Hu Fredy)]. The flap was exposed using a modified coronal tunnel technique with partia papillae elevation.

The protocol was started with intra-muscular incisions with an intrasurcular scalpel (KPA Allen) in each of the treated teeth. Elevation of the flap was performed, using the Allen elevator (PPAELA), till the mucogingival line. After reaching this limit, a partial thickness dissection started using the modified Orban knife, until full tension of the flap was eliminated. The interdental papilla's was partially elevated, without being cut from their alveolar base in order to be able to coronally advance the flap to a coronal position free from tension. The flap was extended one tooth mesial and one tooth distal of the treatment area. The separation of the flap from small muscle fibers and bundles of collagen fibers was carefully carried out until the flap can passively be positioned at least 1mm above the cement enamel junction of all the involved teeth, in order to ensure the passive reposition of the flap and the posterior suture free of tension. After assuring the adequate extension of the tunnel, preparation and decontamination of the roots was carried out using Gracey curettes, eliminating the superficial cement surface in relation to the exposed root portion in order to achieve a smooth and flat surface.

All clinical procedures were performed by the same experienced surgeon who was blind to the treatment modality. All evaluations, procedures and controls will be performed in the dental center and pavilions of the Clinic of the Universidad de los Andes and the International University of Cataluña, were two experienced peridontontis (A.C and A.P) will perform the MCAT.

L-PRF procedure protocol Before the beginning of the surgery, 4 tubes of blood without anticoagulant were taken to obtain the L-PRF. This tubes were filled by venous puncture with a butterfly of diameter 24, they were immediately centrifuged at a speed of 2700 rpm for a period of 12 minutes. The tubes were removed from the centrifuge and the result is a fibrin clot with a platelet content located between a layer of lower red blood cells and acellular plasma on the surface, this clot was removed from the tube and the red blood cells adhering to it are removed and discarded. In continuation, the L-PRF clot was placed in a PRF Box (Process Ltd., Nice, France), where it is covered with a compressor. After approximately 1 minute the result is a membrane or autogenous fibrin matrix. Both the Novomatrix matrix and the connective graft will be left in a cup with part of the plasma exudate resulting from the manufacture of the fibrin matrix for a couple of minutes and will be injected with this biological product by injection with tuberculin syringe once positioned under the tunneled flap.

Conditions
L-PRF, Surgery
Being tested
Acellular dermal matrix + L-Prf, Connective Tissue graft + L-Prf

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acellular dermal matrix + L-PrfDevice

    Incisions: Incisions were made in the gums using a specialized scalpel. Flap Elevation: The gum tissue was lifted away from the underlying bone using a dental elevator.

    Partial Thickness Dissection: The tissue was cut to release tension and allow for easier repositioning.

    Interdental Papilla Elevation: The gum tissue between the teeth was partially lifted.

    Flap Extension: The flap was extended to cover more teeth for better coverage. Tissue Separation: The flap was carefully separated from underlying tissues to allow for proper positioning.

    Root Preparation: The exposed root surfaces were smoothed and cleaned.

  • Connective Tissue graft + L-PrfProcedure or surgery

    Incisions: Incisions were made in the gums using a specialized scalpel. Flap Elevation: The gum tissue was lifted away from the underlying bone using a dental elevator.

    Partial Thickness Dissection: The tissue was cut to release tension and allow for easier repositioning.

    Interdental Papilla Elevation: The gum tissue between the teeth was partially lifted.

    Flap Extension: The flap was extended to cover more teeth for better coverage. Tissue Separation: The flap was carefully separated from underlying tissues to allow for proper positioning.

    Root Preparation: The exposed root surfaces were smoothed and cleaned.

Study groups in NCT06719648
Study groupRoleWhat they receive
Novomatrix and LPRFExperimentalIncisions: Incisions were made in the gums using a specialized scalpel. Flap Elevation: The gum tissue was lifted away from the underlying bone using a dental elevator. Partial Thickness Dissection: The tissue was cut to release tension and allow for easier repositioning. Interdental Papilla Elevation: The gum tissue between the teeth was partially lifted. Flap Extension: The flap was extended to cover more teeth for better coverage. Tissue Separation: The flap was carefully separated from underlying tissues to allow for proper positioning. Root Preparation: The exposed root surfaces were smoothed and cleaned.
Receives: Device: Acellular dermal matrix + L-Prf
Connective tissue graft and LPRFActive comparatorIncisions: Incisions were made in the gums using a specialized scalpel. Flap Elevation: The gum tissue was lifted away from the underlying bone using a dental elevator. Partial Thickness Dissection: The tissue was cut to release tension and allow for easier repositioning. Interdental Papilla Elevation: The gum tissue between the teeth was partially lifted. Flap Extension: The flap was extended to cover more teeth for better coverage. Tissue Separation: The flap was carefully separated from underlying tissues to allow for proper positioning. Root Preparation: The exposed root surfaces were smoothed and cleaned.
Receives: Procedure: Connective Tissue graft + L-Prf

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean root coverage

    amount of root surface covered by healthy gum tissue

    Measured: Baseline, 6 and 12 months

Secondary outcomes (1)
  1. Complete root coverage

    all of the exposed root surface of a tooth has been fully covered by healthy gum tissue

    Measured: Baseline, 6 and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Dec 2024
  2. Study start20 May 2020
  3. Primary completion27 Apr 2023
  4. Study completion28 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06719648
Sponsor's protocol ID
PER-ECL-2019-07
Other IDs
PER-ECL-2019-07
Status last verified
Dec 2024
First submitted
14 Nov 2024
Last updated
6 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Acellular dermal matrix + L-Prf and Connective Tissue graft + L-Prf in people with L-PRF and Surgery, run by Universitat Internacional de Catalunya at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean root coverage (time frame: Baseline, 6 and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in